376 related articles for article (PubMed ID: 7197945)
1. Tiapamil, a new calcium antagonist. 1. Demonstration of calcium antagonistic activity and related studies.
Eigenmann R; Blaber L; Nakamura K; Thorens S; Haeusler G
Arzneimittelforschung; 1981; 31(9):1393-401. PubMed ID: 7197945
[TBL] [Abstract][Full Text] [Related]
2. Calcium blocking properties of piprofurol.
Pourrias B; Huerta F; Santamaria R; Bowe C
Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):223-39. PubMed ID: 4026458
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
[TBL] [Abstract][Full Text] [Related]
4. Effects of nilvadipine on the cardiovascular system in experimental animals.
Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
[TBL] [Abstract][Full Text] [Related]
5. Tissue selectivity of the novel calcium antagonist sesamodil fumarate in isolated smooth muscles and cardiac muscles.
Nishimura K; Miyawaki N; Yamauchi H; Iso T
Arzneimittelforschung; 1990 Mar; 40(3):244-8. PubMed ID: 2112000
[TBL] [Abstract][Full Text] [Related]
6. PN 200-110, a new calcium antagonist: electrophysiological, inotropic, and chronotropic effects on guinea pig myocardial tissue and effects on contraction and calcium uptake of rabbit aorta.
Hof RP; Scholtysik G; Loutzenhiser R; Vuorela HJ; Neumann P
J Cardiovasc Pharmacol; 1984; 6(3):399-406. PubMed ID: 6202964
[TBL] [Abstract][Full Text] [Related]
7. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog.
Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K
Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852
[TBL] [Abstract][Full Text] [Related]
8. Vasodilator mechanism of KB-944, a new calcium antagonist.
Morita T; Kanazawa T; Ito K; Nose T
Arzneimittelforschung; 1982; 32(9):1043-6. PubMed ID: 6890823
[TBL] [Abstract][Full Text] [Related]
9. SR 33557, a novel calcium entry blocker. I. In vitro isolated tissue studies.
Polster P; Christophe B; Van Damme M; Houlliche A; Chatelain P
J Pharmacol Exp Ther; 1990 Nov; 255(2):593-9. PubMed ID: 1700816
[TBL] [Abstract][Full Text] [Related]
10. Bepridil hydrochloride alters potential-dependent and receptor-operated calcium channels in vascular smooth muscle of rabbit aorta.
Flaim SF; Ratz PH; Swigart SC; Gleason MM
J Pharmacol Exp Ther; 1985 Jul; 234(1):63-71. PubMed ID: 2409274
[TBL] [Abstract][Full Text] [Related]
11. Calcium entry blocker activity of cyproheptadine in isolated cardiovascular preparations.
Winquist RJ; Siegl PK; Baskin EP; Bohn DL; Morgan G; Wallace AA
J Pharmacol Exp Ther; 1984 Jul; 230(1):103-9. PubMed ID: 6747822
[TBL] [Abstract][Full Text] [Related]
12. Effects of (-)-desmethoxyverapamil on heart and vascular smooth muscle.
Nawrath H; Raschack M
J Pharmacol Exp Ther; 1987 Sep; 242(3):1090-7. PubMed ID: 3656109
[TBL] [Abstract][Full Text] [Related]
13. Effects of a new dihydropyridine calcium antagonist on vascular smooth muscles, cardiac muscles and [3H]-nitrendipine binding.
Miura A; Ukai Y; Matsuzaki T; Taniguchi N; Hayashi S; Kano S; Kimura Y; Kimura K; Enomoto H
Arzneimittelforschung; 1986 Sep; 36(9):1323-8. PubMed ID: 3790181
[TBL] [Abstract][Full Text] [Related]
14. Verapamil, diltiazem and nifedipine block the depolarization-induced potentiation of norepinephrine contractions in rabbit aorta and porcine coronary arteries.
Hondeghem LM; Ayad MJ; Robertson RM
J Pharmacol Exp Ther; 1986 Dec; 239(3):808-13. PubMed ID: 3795042
[TBL] [Abstract][Full Text] [Related]
15. Cardiac and vascular effects of NZ-105, a novel dihydropyridine derivative, in vitro.
Masuda Y; Iwama T; Yamashita T; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y
Arch Int Pharmacodyn Ther; 1991; 314():57-73. PubMed ID: 1668604
[TBL] [Abstract][Full Text] [Related]
16. Verapamil: a selective antagonist of constrictor substances in dog coronary artery: implications for variant angina.
Angus JA; Brazenor RM; Le Duc MA
Clin Exp Pharmacol Physiol Suppl; 1982; 6():15-28. PubMed ID: 6956474
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular effects of three calcium entry blockers in conscious dogs.
Eigenmann R; Gerold M
Arzneimittelforschung; 1987 Sep; 37(9):1020-5. PubMed ID: 3435596
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the fast Na+ inward current by the Ca2+ channel blocker tiapamil.
Osterrieder W
J Cardiovasc Pharmacol; 1986; 8(6):1101-6. PubMed ID: 2434733
[TBL] [Abstract][Full Text] [Related]
19. In vitro pharmacologic profile of Ro 40-5967, a novel Ca2+ channel blocker with potent vasodilator but weak inotropic action.
Osterrieder W; Holck M
J Cardiovasc Pharmacol; 1989 May; 13(5):754-9. PubMed ID: 2472524
[TBL] [Abstract][Full Text] [Related]
20. Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release.
Griesbacher T; Sametz W; Legat FJ; Diethart S; Hammer S; Juan H
Br J Pharmacol; 1997 Jun; 121(3):469-76. PubMed ID: 9179388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
